Philippe de Moerloose Selected Research

Afibrinogenemia (Fibrinogen Deficiency)

06/2007	Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations.
11/2005	Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenemia.
12/2004	Expression and analysis of a split premature termination codon in FGG responsible for congenital afibrinogenemia: escape from RNA surveillance mechanisms in transfected cells.
12/2003	Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion.

4	Afibrinogenemia (Fibrinogen Deficiency) 06/2007 - 12/2003
3	Venous Thromboembolism 09/2008 - 03/2002
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 04/2008 - 01/2004
2	Hemophilia A (Haemophilia) 02/2008 - 05/2006
1	Thrombosis (Thrombus) 10/2008
1	Thrombocytopenic Purpura (Thrombopenic Purpura) 04/2008
1	Thrombocytopenia (Thrombopenia) 12/2007
1	Tissue Adhesions 02/2005
1	Pulmonary Embolism 12/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2004
1	Acute Coronary Syndrome 12/2004
1	Thrombophlebitis 01/2004

4	Fibrinogen (Factor I)IBA 10/2008 - 12/2003
3	fibrin fragment D (D-dimer)IBA 09/2008 - 09/2002
2	Factor V (Coagulation Factor V)IBA 02/2008 - 05/2006
1	fibrinopeptides gammaIBA 10/2008
1	Immunoglobulins (Immunoglobulin)IBA 04/2008
1	Heparin (Liquaemin)FDA LinkGeneric 12/2007
1	Immunoglobulin G (IgG)IBA 02/2005
1	Thromboplastin (Tissue Factor)IBA 02/2005
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 02/2005
1	fluvastatin FDA Link 02/2005
1	Antiphospholipid AntibodiesIBA 02/2005
1	Nonsense Codon (Nonsense Mutation)IBA 12/2004
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 12/2004
1	AutoantibodiesIBA 12/2004
1	RNA (Ribonucleic Acid)IBA 12/2004
1	Anticardiolipin AntibodiesIBA 01/2004
1	HomocysteineIBA 03/2002